HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

Benzinga · 05/09 11:10
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $5 to $2.